Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
NCT05360914

Hospital at Home for Elderly Acute Ill Patients

Led by Defactum, Central Denmark Region · Updated on 2024-08-09

849

Participants Needed

3

Research Sites

269 weeks

Total Duration

On this page

Sponsors

D

Defactum, Central Denmark Region

Lead Sponsor

I

Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark

Collaborating Sponsor

AI-Summary

What this Trial Is About

Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.

CONDITIONS

Official Title

Hospital at Home for Elderly Acute Ill Patients

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 65 years and older
  • Diagnosed with stable acute medical conditions such as cystitis, erysipelas, or pneumonia
  • Living in their own home or a nursing home before entering the study
  • Residing in one of the three municipalities: Viborg, Skive, or Silkeborg
  • Have been seen by their general practitioner or pre-hospital service for the current illness
  • Speak and understand Danish
  • Able to give informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Unable to give written consent
  • Municipal acute team care capacity is fully utilized

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Silkeborg municipality

Silkeborg, Denmark, 8600

Actively Recruiting

2

Skive municipality

Skive, Denmark

Actively Recruiting

3

Viborg municipality

Viborg, Denmark

Actively Recruiting

Loading map...

Research Team

C

Camilla Palmhøj Nielsen, Ph.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here